Blog Archives

Personalisierte Medizin per se schütz nicht vor schwerwiegenden Arzneimittelnebenwirkungen

25. April 2017 – Personalisierte Medizin per se schütz nicht vor schwerwiegenden Arzneimittelnebenwirkungen. Dies ist eine wichtige Erkenntnis für Patienten / Patientinnen welche eine sogenannte personalisierte (gezielte) Therapie erhalten. Die Informationen und Bewerbungen rund um Arzneimittel welche personalisierte und gezielte Therapien erlauben, könnten nämlich leicht den Eindruck erwecken,

Read more ›

Tags: , , , , , , , , ,

Risiko von Rhabdomyolyse unter Mirtazapin (Remeron) Therapie

31. Juli 2016 – Die Zulassungsinhaberin von Mirtazapin (Remeron) in der Schweiz, MSD Merck Sharp & Dome AG, hat am 27. Juli. 2016 in Übereinstimmung mit Swissmedic, dem Schweizer Heilmittelinstitut, darüber informiert, dass nach der Überprüfung der derzeit verfügbaren Sicherheitsdaten, welche aus der Post-Marketing Überwachung stammen,  

Read more ›

Tags: , , , , ,

Immunvermittelte nekrostisierende Myopathie: Eine seltene, jedoch bedrohliche Nebenwirkung unter Statin-Therapie

13. November 2015 – In den letzten Jahren wurden Statine (HMG-CoA-Reduktasehemmer) als ein möglicher Auslöser der seltenen immunvermittelten nekrotisierenden Myopathie (englisch als immune-mediated necrotising myopathy (IMNM) bezeichnet) identifiziert.

Swissmedic (Das Schweizerische Heilmittelinstitut) hat dazu am 21. Oktober 2015 eine sogenannte HPC (Health Profesional Communication) veröffentlicht.

Read more ›

Tags: , , , , , , ,

thasso: zustände

thasso: neueste tweets

thasso: kürzliche kommentare

View my Flipboard Magazine.

thasso: kategorien

thasso: archive

thasso: einfacher chat

You must be a registered user to participate in this chat.

  • Researchers develop new approach to study the genetics of human disease July 7, 2020
    Many heritable immune diseases such as rheumatoid arthritis and blood-cell related traits derive from critical proteins not being made or not functioning correctly. But exactly how a person's genes, the regulation of these genes and how the resulting proteins interact to cause disease is not widely understood.
  • Common inherited genetic variant identified as frequent cause of deafness in adults July 6, 2020
    A common inherited genetic variant is a frequent cause of deafness in adults, meaning that many thousands of people are potentially at risk, reveals research published online in the Journal of Medical Genetics.
  • Rsearchers create an analytic tool that opens a new frontier of cancer discovery July 6, 2020
    Gene coding regions constitute 2% of the human genome. St. Jude Children's Research Hospital scientists have developed a computational tool to identify alterations that drive tumor formation in the remaining 98% of the genome. The method will aid discovery of oncogenes and advances in precision medicine for children and adults with cancer.
  • Discovery of new disease-susceptibility gene for steroid-sensitive nephrotic syndrome July 3, 2020
    An international research collaboration, including Professor Iijima Kazumoto et al. (of the Department of Pediatrics, Kobe University Graduate School of Medicine) has revealed that NPHS1 is a disease-susceptibility gene for steroid-sensitive nephrotic syndrome in children. The NPHS1 gene encodes nephrin, a component protein for the renal glomerulus slit diaphragm, which prevents protein from being passed […]
  • How digital tools can advance quality and equity in genomic medicine July 3, 2020
    The pandemic has forced health care providers to find new ways to connect with patients through screens. For genetic specialists, who provide patients and families with genetic testing for conditions linked to DNA, connecting with patients is an important part of helping them make informed medical decisions.
  • A novel therapeutic target for recovery after stroke July 7, 2020
    IBS researchers have discovered a new mechanism to explain the effects of subcortical strokes and a new possible therapeutic approach.
  • Scientists create new device to light up the way for quantum technologies July 7, 2020
    Researchers at CRANN and the School of Physics at Trinity College Dublin, Ireland, have created an innovative new device that will emit single particles of light, or photons, from quantum dots that are the key to practical quantum computers, quantum communications, and other quantum devices.
  • Long-acting injectable form of HIV prevention outperforms daily pill in NIH study July 7, 2020
    A pre-exposure prophylaxis (PrEP) regimen containing an investigational long-acting form of the HIV drug cabotegravir injected once every 8 weeks was more effective than daily oral Truvada at preventing HIV acquisition among cisgender men who have sex with men and transgender women who have sex with men in a clinical trial sponsored by NIH. Findings […]
  • Portable system boosts laser precision, at room temperature July 7, 2020
    Physicists at MIT have designed a quantum "light squeezer" that reduces quantum noise in an incoming laser beam by 15 percent. It is the first system of its kind to work at room temperature, making it amenable to a compact, portable setup that may be added to high-precision experiments to improve laser measurements where quantum […]
  • Fighting E. coli with E. coli July 7, 2020
    According to findings published this week in mBio, Nissle, a strain of Escherichia coli, is harmless to intestinal tissue and may protect the gut from enterohemorrhagic E. coli, a pathogen that produces Shiga toxin.